Merion R M, Burtch G D, Ham J M, Turcotte J G, Campbell D A
Department of Surgery, University of Michigan Medical School, Ann Arbor.
Transplantation. 1989 Sep;48(3):438-43. doi: 10.1097/00007890-198909000-00018.
Hepatic artery complications after liver transplantation are uncommon, but represent an important cause of morbidity and mortality. In addition, these complications tax an already limited supply of donor organs because of the frequent need for retransplantation in this group of patients. In this study, we examined the incidence of hepatic arterial anomalies in donors and recipients of orthotopic liver transplants, focusing on the techniques that are available for hepatic arterial reconstruction and on the occurrence of hepatic arterial complications. A total of 77 liver transplants were carried out in 68 patients. Standard recipient anatomy was present in 60 of 68 patients (88%). Anomalous vessels were identified in eight patients (12%), including six cases of replaced right hepatic artery (9%) and two cases of replaced left hepatic artery (3%). Donor liver arterial anatomy was standard in 62 cases (80%). Anomalous arterial supply was identified in 15 of 77 donor livers (20%), including replaced left hepatic artery in nine (12%) and replaced right hepatic artery in six (8%). A variety of methods were used to manage the anomalous vessels. There was one hepatic artery pseudoaneurysm, three cases of hepatic artery thrombosis (4%), and one patient developed a dissection of the native celiac axis. In primary transplants, utilization of the recipient's proper hepatic artery was associated with a significantly higher risk of hepatic artery thrombosis (P less than 0.04) when compared with the common hepatic artery or the branch patch technique. Use of a Carrel patch on the donor artery was associated with a significantly reduced incidence of hepatic artery thrombosis (P less than 0.0003). For retransplantation, it is recommended that a more proximal recipient anastomotic site be chosen. An innovative method is described that provides increased length of the donor arterial supply without the use of an arterial graft.
肝移植术后肝动脉并发症并不常见,但却是发病和死亡的重要原因。此外,由于这类患者经常需要再次移植,这些并发症加重了本就有限的供体器官供应负担。在本研究中,我们检查了原位肝移植供体和受体肝动脉异常的发生率,重点关注可用于肝动脉重建的技术以及肝动脉并发症的发生情况。68例患者共进行了77例肝移植。68例患者中有60例(88%)具有标准的受体解剖结构。8例患者(12%)发现有异常血管,包括6例替代右肝动脉(9%)和2例替代左肝动脉(3%)。62例(80%)供肝的肝动脉解剖结构为标准型。77例供肝中有15例(20%)发现有异常动脉供应,包括9例替代左肝动脉(12%)和6例替代右肝动脉(8%)。采用了多种方法处理异常血管。发生1例肝动脉假性动脉瘤、3例肝动脉血栓形成(4%),1例患者出现了天然腹腔干夹层。在初次移植中,与肝总动脉或分支补片技术相比,利用受体的肝固有动脉发生肝动脉血栓形成的风险显著更高(P<0.04)。在供体动脉上使用卡雷尔补片可使肝动脉血栓形成的发生率显著降低(P<0.0003)。对于再次移植,建议选择更近端的受体吻合部位。描述了一种创新方法,无需使用动脉移植物即可增加供体动脉供应的长度。